Details of the Drug

General Information of Drug (ID: DM6X509)

Drug Name

V116

Indication

Disease Entry	ICD 11	Status	REF
Pneumococcal infection	CA00-CA40	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05425732) A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-na?ve Adults. U.S.National Institutes of Health.